MoneyWorks4Me

Ajanta Pharma - Quaterly Results

28 Oct 2024 Evaluate
A fair growth of 19.44% in the revenue at Rs. 11289.10 millions was reported in the September 2024 quarter as compared to Rs. 9451.80 millions during year-ago period.A humble growth in net profit of 10.65% reported in the quarter ended September 2024 to Rs. 2349.80  millions from Rs. 2123.60 millions.Operating Profit saw a handsome growth to 3432.50 millions from 3258.10 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 11289.10 9451.80 19.44 22061.80 19597.60 12.57 39711.20 34112.70 16.41
Other Income 403.40 521.60 -22.66 687.10 836.20 -17.83 1164.80 1327.50 -12.26
PBIDT 3432.50 3258.10 5.35 6874.50 6341.70 8.40 12359.10 8320.30 48.54
Interest 7.30 22.70 -67.84 14.50 30.20 -51.99 68.00 52.30 30.02
PBDT 3425.20 3235.40 5.87 6860.00 6311.50 8.69 12291.10 8268.00 48.66
Depreciation 333.20 330.40 0.85 662.40 652.80 1.47 1321.60 1269.50 4.10
PBT 3092.00 2905.00 6.44 6197.60 5658.70 9.52 10969.50 6998.50 56.74
TAX 742.20 781.40 -5.02 1487.50 1414.70 5.15 2897.10 1411.30 105.28
Deferred Tax 30.90 29.10 6.19 62.00 56.60 9.54 121.30 -29.30 -513.99
PAT 2349.80 2123.60 10.65 4710.10 4244.00 10.98 8072.40 5587.20 44.48
Equity 250.70 252.70 -0.79 250.70 252.70 -0.79 252.70 252.70 0.00
PBIDTM(%) 30.41 34.47 -11.79 31.16 32.36 -3.71 31.12 24.39 27.60
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..